PBH FY2025 SEC EDGAR DEF 14A #65 of 168 in industry

Prestige Consumer Healthcare Inc. CEO pay ratio

The CEO earned $6.0M in FY2025 against median worker pay of $110,232 · Chemicals & Pharmaceuticals.

Chemicals & Pharmaceuticals peers All rankings
State
NY
Filing date
2026-06-29
Industry
Chemicals & Pharmaceuticals
Industry rank
#65/168

Data updated August 2026

Subscribe to Prestige Consumer Healthcare Inc. CEO pay filing updates (RSS)

CEO-to-worker pay ratio
54:1
Moderate (Scale: 0–1000:1)
CEO pay
$6.0M
Median worker
$110,232

Answer first

Prestige Consumer Healthcare Inc.'s FY2025 CEO total of $6.0M ranks #851 of 1,423 complete filings; its 54:1 pay ratio ranks #941. Dollar rank is not ratio rank.

According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $110,232. Industry placement uses the FY2025 SIC-28 peer cohort (# 65 of 168, 62nd percentile - above the industry median pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Dollar rank
#851
$6.0M of 1,423 FY2025
Ratio rank
#941
54:1 of 1,423
Industry pct
62nd
above the industry median pay ratio

How Prestige Consumer Healthcare Inc. ranks nationally

Prestige Consumer Healthcare Inc. CEO pay vs. every FY2025 complete filing

Total CEO compensation, the full national distribution, this company marked

$6,004,547 40th percentile higher than 40% of 1,423 companies

$0–$2,500,000: 304 companies (21%). Below this entry. $2,500,000–$5,000,000: 182 companies (13%). Below this entry. $5,000,000–$7,500,000: 208 companies (15%). This entry sits in this band. $7,500,000–$10,000,000: 192 companies (13%). Above this entry. $10,000,000–$12,500,000: 139 companies (10%). Above this entry. $12,500,000–$15,000,000: 91 companies (6%). Above this entry. $15,000,000–$17,500,000: 88 companies (6%). Above this entry. $17,500,000–$20,000,000: 54 companies (4%). Above this entry. $20,000,000–$22,500,000: 24 companies (2%). Above this entry. $22,500,000–$25,000,000: 34 companies (2%). Above this entry. $25,000,000–$27,500,000: 24 companies (2%). Above this entry. $27,500,000–$30,000,000: 16 companies (1%). Above this entry. $30,000,000–$32,500,000: 10 companies (1%). Above this entry. $32,500,000–$35,000,000: 7 companies (0%). Above this entry. $35,000,000–$37,500,000: 9 companies (1%). Above this entry. $37,500,000–$40,000,000: 6 companies (0%). Above this entry. $40,000,000–$42,500,000: 1 companies (0%). Above this entry. $42,500,000–$45,000,000: 1 companies (0%). Above this entry. $45,000,000–$47,500,000: 6 companies (0%). Above this entry. $47,500,000–$50,000,000: 27 companies (2%). Above this entry. This company $0 $50M+ every complete-filing company, bucketed by value

Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025

Prestige Consumer Healthcare Inc. vs. Chemicals & Pharmaceuticals peers

CEO total pay ($6.0M) against pay ratio (54:1) for Prestige Consumer Healthcare Inc. (marked) and its 4 closest same-industry peers, against the Chemicals & Pharmaceuticals industry median on both axes.

Pay + gap both highContained pay, wide gapHigh pay, contained gapBelow peer norms on both4866318.39162476.913458635.517754794.122050952.841.4:144.9:148.5:152.1:155.6:1CEO total payPay ratio (CEO : median worker)Prestige Consumer Healthcare Inc., CEO total pay: 6004547 · Pay ratio (CEO : median worker): 54:1Prestige Consumer Healthcare Inc.Arrowhead Pharmaceuticals, Inc., CEO total pay: 8968410 · Pay ratio (CEO : median worker): 55:1Arrowhead Pharmaceuticals, Inc.AbCellera Biologics Inc., CEO total pay: 6350188 · Pay ratio (CEO : median worker): 52:1AbCellera Biologics Inc.AdvanSix Inc., CEO total pay: 5647438 · Pay ratio (CEO : median worker): 51:1AdvanSix Inc.Viking Therapeutics, Inc., CEO total pay: 21269833 · Pay ratio (CEO : median worker): 49:1Viking Therapeutics, Inc.
Prestige Consumer Healthcare Inc. vs. Chemicals & Pharmaceuticals peers, plotted against the industry's $7.9M median CEO total and 42:1 median pay ratio.

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2025

A component-level pay breakdown is not reported in Prestige Consumer Healthcare Inc.'s structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · Prestige Consumer Healthcare Inc.

Complete DEF 14A pay-ratio filings for this CIK across FY2021–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
54:1
FY2025
vs prior FY
-21:1
from FY2024 75:1
CEO $ YoY
-3%
$6.0M latest
Filings shown
5
FY2021–2025
Prestige Consumer Healthcare Inc. CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2021 $6.0M - $85,063 71:1 -
2022 $5.6M -7.4% $86,266 65:1 -6:1
2023 $5.8M +3.2% $82,936 69:1 +4:1
2024 $6.2M +7.5% $82,850 75:1 +6:1
2025 $6.0M -3% $110,232 54:1 -21:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 1295947, FY2021–2025. Adjacent-year deltas only.

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
54:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$6.0M
Companies in Industry
168
vs. Industry Median
Above
#65 of 168 by pay ratio in this industry View all companies in Chemicals & Pharmaceuticals →

Prestige Consumer Healthcare Inc.: MODEST · HEAVY pay ratio

Prestige Consumer Healthcare Inc. disclosed 54:1 CEO-to-worker pay and $6.0M CEO total in FY2025. the CEO earned 54× the median employee ($110,232) in FY2025.

Median employee $110,232 (HIGH-MED); MODEST · HEAVY stamps put about 54 median-wage years per CEO year.

CEO Total Pay

$6.0M

FY2025 Summary Compensation, below median

Pay Ratio

54:1

Near industry median

What FY2025 shows for Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare Inc. disclosed 54:1 CEO-to-worker pay and $6.0M CEO total in FY2025. The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Prestige Consumer Healthcare Inc.'s $6.0M CEO total is at or below the $7.9M industry median CEO pay.

Dollar rank #851 and ratio rank #941 split - treat 54:1 as a disclosure, not a fairness score. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2025

Total Compensation
$6.0M
Median Employee Pay
$110,232
Pay Ratio
54:1
Filing Date
2026-06-29

Company Info

Ticker
PBH
CIK
1295947
Industry
Chemicals & Pharmaceuticals
SIC Code
2834
State
NY
View SEC filings →
SEC EDGAR DEF 14A for CIK 1295947, FY2025. Informational only, not investment advice. Verify on EDGAR.

Read our methodology - how this data is sourced, computed, and verified. Prestige Consumer Healthcare Inc. disclosed 54:1 CEO-to-worker pay and $6.0M CEO total in FY2025.

Read with Prestige Consumer Healthcare Inc.

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps MODEST · HEAVY · HIGH-MED.

Bank Of Hawaii Corp · HEAVY

ABS(ceo_total_comp) peer at $6.0M (Δ $11K heavier vs Prestige Consumer Healthcare Inc.); MID · HIGH-MED vs this page's MODEST · HEAVY · HIGH-MED.
Mgp Ingredients Inc · MID$

ABS(ceo_total_comp) peer at $6.0M (Δ $30K lighter vs Prestige Consumer Healthcare Inc.); MODEST · HIGH-MED vs this page's MODEST · HEAVY · HIGH-MED.
Columbus Mckinnon Corp · MID$

ABS(ceo_total_comp) peer at $6.0M (Δ $33K lighter vs Prestige Consumer Healthcare Inc.); MID · PAR-MED vs this page's MODEST · HEAVY · HIGH-MED.
Summit Midstream Corp · MID$

ABS(ceo_total_comp) peer at $6.0M (Δ $34K lighter vs Prestige Consumer Healthcare Inc.); FLOOR · ELITE-MED vs this page's MODEST · HEAVY · HIGH-MED.
Arrowhead Pharmaceuticals, Inc. (SIC 28 pole)

Arrowhead Pharmaceuticals, Inc. stamps MODEST · HEAVY nearest in-SIC by ABS(pay_ratio) to Prestige Consumer Healthcare Inc.'s MODEST filing.
National dual ranks · #851/#941

Prestige Consumer Healthcare Inc.'s FY2025 package sits #851 by CEO dollars and #941 by ratio under HEAVY · MODEST.
Ratio primer · MODEST

Prestige Consumer Healthcare Inc.'s MODEST stamp sits in the lower Item 402(u) band - start with how the ratio is disclosed before comparing peers.
Data sourced from SEC EDGAR DEF 14A for Prestige Consumer Healthcare Inc. (CIK 1295947), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.